Go Pro

AstroNova (ALOT) Financials

AstroNova logo
$28.62 0.00 (0.00%)
Closing price 07/17/2026 04:00 PM Eastern
Extended Trading
$28.69 +0.07 (+0.26%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for AstroNova

Annual Income Statements for AstroNova

This table shows AstroNova's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
4.53 4.23 3.29 5.73 1.76 1.28 6.43 2.66 4.69 -14 -2.38
Consolidated Net Income / (Loss)
4.53 4.23 3.29 5.73 1.76 1.28 6.43 2.66 4.69 -14 -2.38
Net Income / (Loss) Continuing Operations
4.53 4.23 3.29 5.73 1.76 1.28 6.43 2.66 4.69 -14 -2.38
Total Pre-Tax Income
6.91 6.61 5.16 7.31 1.37 2.18 7.03 3.41 6.07 -12 -2.54
Total Operating Income
5.93 6.28 5.41 8.72 2.43 2.43 4.26 5.44 8.80 -8.64 1.21
Total Gross Profit
38 39 44 54 49 41 44 48 50 51 48
Total Revenue
95 98 113 137 133 116 117 143 148 151 151
Operating Revenue
95 98 113 137 133 116 117 143 148 151 151
Total Cost of Revenue
57 59 69 83 85 75 74 94 99 101 103
Operating Cost of Revenue
57 59 69 83 85 75 74 94 99 101 103
Total Operating Expenses
32 33 39 45 46 39 39 43 41 59 46
Selling, General & Admin Expense
7.03 7.94 8.90 11 11 9.42 9.55 11 11 16 16
Marketing Expense
18 19 22 26 27 23 23 24 23 24 23
Research & Development Expense
6.95 6.31 7.45 7.81 8.08 6.21 6.75 6.82 6.34 6.05 6.79
Impairment Charge
- - - - - - - 0.00 0.00 13 0.30
Total Other Income / (Expense), net
0.98 0.32 -0.26 -1.41 -1.06 -0.25 2.78 -2.03 -2.72 -3.65 -3.74
Interest Expense
- - 0.40 0.73 0.68 0.96 -3.79 1.68 2.70 3.21 3.50
Other Income / (Expense), net
0.90 0.25 -0.02 -0.68 -0.38 0.70 -1.01 -0.36 -0.03 -0.44 -0.24
Income Tax Expense
2.38 2.38 1.87 1.58 -0.39 0.90 0.61 0.75 1.38 2.20 -0.16
Basic Earnings per Share
$0.62 $0.57 $0.48 $0.83 $0.25 $0.18 $0.89 $0.36 $0.63 ($1.93) ($0.31)
Weighted Average Basic Shares Outstanding
7.29M 7.42M 6.91M 6.88M 7.02M 7.10M 7.21M 7.31M 7.42M 7.51M 7.61M
Diluted Earnings per Share
$0.61 $0.56 $0.47 $0.81 $0.24 $0.18 $0.88 $0.36 $0.63 ($1.93) ($0.31)
Weighted Average Diluted Shares Outstanding
7.47M 7.57M 7.02M 7.08M 7.24M 7.17M 7.34M 7.37M 7.50M 7.51M 7.61M
Weighted Average Basic & Diluted Shares Outstanding
7.30M 7.40M 6.80M 6.90M 7.10M 7.21M 7.32M 7.40M 7.74M 7.57M 7.69M

Quarterly Income Statements for AstroNova

This table shows AstroNova's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 7/29/2023 10/28/2023 4/27/2024 8/3/2024 11/2/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-1.62 2.75 1.18 -0.31 0.24 -16 -0.38 -1.24 0.38 -1.14 0.65
Consolidated Net Income / (Loss)
-1.62 2.75 1.18 -0.31 0.24 -16 -0.38 -1.24 0.38 -1.14 0.65
Net Income / (Loss) Continuing Operations
-1.62 2.75 1.18 -0.31 0.24 -16 -0.38 -1.24 0.38 -1.14 0.65
Total Pre-Tax Income
-2.01 3.70 0.75 -0.05 0.27 -13 -0.30 -1.70 0.25 -0.79 0.85
Total Operating Income
-1.20 4.62 1.35 1.06 1.26 -12 0.57 -0.71 1.29 0.06 1.56
Total Gross Profit
9.71 15 12 14 14 11 12 12 14 9.15 14
Total Revenue
36 38 33 41 40 37 38 36 39 38 39
Operating Revenue
36 38 33 41 40 37 38 36 39 38 39
Total Cost of Revenue
26 23 21 26 27 27 26 24 25 28 25
Operating Cost of Revenue
26 23 21 26 27 27 26 24 25 28 25
Total Operating Expenses
11 10 11 13 12 23 11 12 13 9.10 13
Selling, General & Admin Expense
2.65 2.73 3.37 5.12 3.86 3.25 4.25 5.03 5.12 1.24 5.36
Marketing Expense
6.70 5.74 5.66 6.73 6.75 5.11 5.61 5.73 5.59 6.09 5.69
Research & Development Expense
1.56 1.68 1.60 1.41 1.84 1.19 1.53 1.58 1.90 1.77 1.81
Impairment Charge
- - - - 0.00 - 0.00 - 0.30 - 0.00
Total Other Income / (Expense), net
-0.81 -0.92 -0.60 -1.11 -0.99 -0.95 -0.87 -0.99 -1.04 -0.84 -0.71
Interest Expense
0.67 0.63 0.48 0.94 0.94 0.85 0.90 0.89 0.83 0.89 0.68
Other Income / (Expense), net
-0.14 -0.29 -0.12 -0.17 -0.05 -0.10 0.03 -0.10 -0.21 0.05 -0.04
Income Tax Expense
-0.39 0.95 -0.43 0.26 0.03 2.34 0.08 -0.45 -0.13 0.35 0.20
Basic Earnings per Share
($0.22) $0.37 $0.16 ($0.04) $0.03 ($2.08) ($0.05) ($0.16) $0.05 ($0.15) $0.09
Weighted Average Basic Shares Outstanding
7.42M 7.43M 7.46M 7.52M 7.52M 7.51M 7.56M 7.61M 7.63M 7.61M 7.68M
Diluted Earnings per Share
($0.22) $0.37 $0.15 ($0.04) $0.03 ($2.07) ($0.05) ($0.16) $0.05 ($0.15) $0.08
Weighted Average Diluted Shares Outstanding
7.42M 7.48M 7.63M 7.52M 7.58M 7.51M 7.56M 7.61M 7.70M 7.61M 7.77M
Weighted Average Basic & Diluted Shares Outstanding
7.42M 7.43M 7.51M 7.52M 7.53M 7.57M 7.60M 7.64M 7.64M 7.69M 7.75M

Annual Cash Flow Statements for AstroNova

This table details how cash moves in and out of AstroNova's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Change in Cash & Equivalents
2.09 8.06 -7.92 -2.64 -3.29 7.19 -6.16 -1.33 0.58 0.52 -0.98
Net Cash From Operating Activities
7.73 6.95 3.72 5.01 3.22 16 1.39 -2.94 12 4.85 12
Net Cash From Continuing Operating Activities
7.73 6.95 3.72 5.01 3.22 16 1.39 -2.94 12 4.85 12
Net Income / (Loss) Continuing Operations
4.53 4.23 3.29 5.73 1.76 1.28 6.43 2.66 4.69 -14 -2.38
Consolidated Net Income / (Loss)
4.53 4.23 3.29 5.73 1.76 1.28 6.43 2.66 4.69 -14 -2.38
Depreciation Expense
2.07 2.43 3.99 6.15 6.28 5.98 3.99 3.92 4.27 4.94 5.13
Amortization Expense
- - 0.03 0.05 0.05 0.08 0.04 0.03 0.02 0.03 0.04
Non-Cash Adjustments To Reconcile Net Income
1.14 0.60 1.58 1.89 1.78 1.82 -2.28 4.43 3.39 15 2.72
Changes in Operating Assets and Liabilities, net
-0.01 -0.31 -5.17 -8.81 -6.64 6.38 -6.80 -14 -0.02 -0.41 6.22
Net Cash From Investing Activities
-3.54 3.12 -21 -1.53 -2.91 -2.59 -1.80 -17 -0.88 -20 -0.22
Net Cash From Continuing Investing Activities
-3.54 3.12 -21 -1.53 -2.91 -2.59 -1.80 -17 -0.88 -20 -0.22
Purchase of Property, Plant & Equipment
-3.06 -1.24 -17 -3.05 -2.91 -2.59 -1.80 -0.23 -0.88 -1.17 -0.33
Acquisitions
-7.36 - -9.01 - - 0.00 0.00 -17 0.00 -19 0.00
Sale of Property, Plant & Equipment
2.09 0.73 0.09 - - - - - 0.00 0.00 0.11
Net Cash From Financing Activities
-1.60 -2.00 9.06 -6.11 -3.74 -5.14 -5.56 19 -11 15 -13
Net Cash From Continuing Financing Activities
-1.60 -2.00 9.06 -6.11 -3.74 -5.14 -5.56 19 -11 15 -13
Repayment of Debt
- - -1.06 -5.13 -5.21 -18 -13 15 -2.10 2.49 -31
Issuance of Debt
- - 24 1.50 5.00 15 10 6.00 -7.00 15 20
Issuance of Common Equity
0.39 0.08 0.54 1.31 0.78 0.10 0.16 0.16 0.21 0.16 0.05
Other Financing Activities, net
0.07 - -1.44 -1.86 -2.34 -2.11 -2.39 -2.26 -2.08 -2.35 -1.42
Effect of Exchange Rate Changes
-0.50 - - - - -0.63 - 0.11 - 0.57 0.36
Cash Interest Paid
- - 0.25 0.64 0.53 0.68 0.34 0.79 2.34 2.70 3.04
Cash Income Taxes Paid
2.26 -0.08 1.94 3.47 2.91 0.45 2.41 0.31 1.69 2.21 0.63

Quarterly Cash Flow Statements for AstroNova

This table details how cash moves in and out of AstroNova's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/28/2023 1/31/2024 4/27/2024 8/3/2024 11/2/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026
Net Change in Cash & Equivalents
0.30 -0.30 -0.54 0.83 -0.39 0.62 0.30 -1.50 -0.25 0.47 0.60
Net Cash From Operating Activities
1.18 6.45 6.90 0.16 -4.74 2.52 4.40 0.25 3.42 3.67 3.02
Net Cash From Continuing Operating Activities
1.18 6.45 6.90 0.16 -4.74 2.52 4.40 0.25 3.42 3.67 3.02
Net Income / (Loss) Continuing Operations
2.75 2.71 1.18 -0.31 0.24 -16 -0.38 -1.24 0.38 -1.13 0.65
Consolidated Net Income / (Loss)
2.75 2.71 1.18 -0.31 0.24 -16 -0.38 -1.24 0.38 -1.13 0.65
Depreciation Expense
1.01 1.11 0.91 1.31 1.41 1.32 1.35 1.22 1.03 1.53 1.25
Amortization Expense
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Non-Cash Adjustments To Reconcile Net Income
0.31 0.28 0.33 0.48 0.35 14 0.31 0.50 1.16 0.75 0.39
Changes in Operating Assets and Liabilities, net
-2.90 2.35 4.48 -1.32 -6.75 3.18 3.11 -0.24 0.84 2.51 0.72
Net Cash From Investing Activities
-0.79 0.40 -0.49 -21 1.36 -0.08 -0.06 -0.05 0.01 -0.13 -0.04
Net Cash From Continuing Investing Activities
-0.79 0.40 -0.49 -21 1.36 -0.08 -0.06 -0.05 0.01 -0.13 -0.04
Purchase of Property, Plant & Equipment
-0.79 0.40 -0.49 -0.34 -0.26 -0.08 -0.06 -0.05 -0.09 -0.14 -0.04
Net Cash From Financing Activities
-0.13 -6.99 -6.97 22 2.97 -2.16 -4.23 -1.74 -3.76 -3.13 -2.25
Net Cash From Continuing Financing Activities
-0.13 -6.99 -6.97 22 2.97 -2.16 -4.23 -1.74 -3.76 -3.13 -2.25
Repayment of Debt
0.33 0.33 -6.21 2.90 -3.43 9.24 -0.83 -1.45 -23 -2.85 -0.81
Issuance of Debt
- -7.00 - - 6.86 -11 -2.87 - 20 - -0.82
Issuance of Common Equity
0.03 0.06 0.05 0.03 0.03 0.05 0.05 - - - 0.00
Other Financing Activities, net
-0.48 -0.38 -0.81 -0.38 -0.50 -0.67 -0.58 -0.29 -0.27 -0.28 -0.61
Other Net Changes in Cash
- - - - - - 0.20 - - - -0.14
Cash Interest Paid
0.51 0.65 0.41 0.60 0.88 0.81 0.77 0.75 0.77 0.75 0.65
Cash Income Taxes Paid
0.02 0.41 0.09 0.45 0.96 0.71 -0.10 0.66 0.06 0.01 0.05

Annual Balance Sheets for AstroNova

This table presents AstroNova's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Total Assets
78 84 122 119 117 115 115 139 133 146 138
Total Current Assets
55 61 63 63 60 61 64 80 77 78 71
Cash & Equivalents
10 18 10 7.53 4.25 11 5.28 3.95 4.53 5.05 4.07
Accounts Receivable
15 16 22 23 20 17 17 22 23 21 19
Inventories, net
15 20 28 30 34 30 35 51 46 48 43
Prepaid Expenses
3.88 1.39 1.25 1.43 2.19 1.81 3.63 2.89 2.72 3.86 4.40
Plant, Property, & Equipment, net
9.81 9.28 9.75 10 11 12 11 14 14 16 14
Total Noncurrent Assets
14 13 50 46 45 43 40 45 42 52 53
Goodwill
4.52 4.52 13 12 12 13 12 15 15 16 17
Intangible Assets
5.98 5.26 34 30 25 22 19 21 19 24 21
Noncurrent Deferred & Refundable Income Taxes
3.05 2.81 1.83 2.93 5.08 5.94 5.59 6.91 6.88 8.43 9.83
Other Noncurrent Operating Assets
0.09 0.37 1.15 1.06 2.75 2.49 2.79 2.36 2.04 3.47 4.03
Total Liabilities & Shareholders' Equity
78 84 122 119 117 115 115 139 133 146 138
Total Liabilities
11 13 59 49 45 41 34 55 43 70 61
Total Current Liabilities
9.55 12 26 25 27 21 20 37 30 46 38
Short-Term Debt
- - 5.50 6.71 12 5.33 1.00 18 12 28 19
Accounts Payable
3.19 4.96 12 5.96 4.41 5.73 8.59 8.48 8.07 7.93 6.81
Accrued Expenses
2.21 2.17 2.41 2.91 4.71 3.87 4.11 3.31 2.71 4.46 4.70
Current Deferred Revenue
0.53 0.47 0.37 0.37 0.47 0.29 0.26 1.89 1.34 0.54 0.49
Current Deferred & Payable Income Tax Liabilities
0.18 1.45 0.68 0.55 0.00 0.66 0.32 0.79 0.35 0.00 0.69
Current Employee Benefit Liabilities
3.44 2.94 2.90 5.02 2.70 2.92 3.51 2.75 2.92 3.75 4.39
Other Current Liabilities
- - 2.24 3.14 2.77 2.18 2.24 2.29 2.64 2.05 1.99
Total Noncurrent Liabilities
1.04 1.14 33 25 19 20 14 17 13 23 22
Long-Term Debt
- - 18 13 7.72 12 8.15 12 10 19 18
Noncurrent Deferred Revenue
- - - - - - 0.00 0.67 0.00 0.00 0.90
Other Noncurrent Operating Liabilities
- 1.13 14 12 10 7.91 5.57 4.46 3.06 4.42 3.14
Total Equity & Noncontrolling Interests
67 71 64 70 71 75 81 84 90 76 77
Total Preferred & Common Equity
67 71 64 70 71 75 81 84 90 76 77
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
67 71 64 70 71 75 81 84 90 76 77
Common Stock
46 48 51 54 57 59 60 62 63 65 67
Retained Earnings
42 44 46 50 49 50 57 59 64 49 47
Treasury Stock
-20 -21 -32 -33 -33 -34 -34 -34 -35 -35 -35
Accumulated Other Comprehensive Income / (Loss)
-0.98 -1.06 -0.17 -0.82 -1.09 -0.38 -1.75 -2.24 -2.22 -3.35 -1.80

Quarterly Balance Sheets for AstroNova

This table presents AstroNova's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 7/29/2023 10/28/2023 4/27/2024 8/3/2024 11/2/2024 4/30/2025 7/31/2025 10/31/2025 4/30/2026
Total Assets
133 134 127 169 166 150 143 141 140
Total Current Assets
75 77 70 83 83 81 75 74 75
Cash & Equivalents
4.53 4.83 3.99 4.82 4.43 5.35 3.86 3.61 4.68
Accounts Receivable
18 22 18 23 25 21 19 20 22
Inventories, net
49 47 45 51 49 51 48 45 44
Prepaid Expenses
2.91 3.06 3.24 4.22 5.24 3.01 4.45 5.02 4.43
Plant, Property, & Equipment, net
14 14 14 19 18 18 17 15 14
Total Noncurrent Assets
44 43 42 67 65 52 51 52 52
Goodwill
15 14 15 25 25 15 15 17 17
Intangible Assets
20 19 18 27 25 23 23 22 21
Noncurrent Deferred & Refundable Income Taxes
6.91 6.90 6.88 11 11 8.53 8.54 8.57 9.78
Other Noncurrent Operating Assets
2.43 2.30 2.31 3.67 3.67 4.45 4.36 4.22 3.85
Total Liabilities & Shareholders' Equity
133 134 127 169 166 150 143 141 140
Total Liabilities
48 47 35 77 74 74 67 64 62
Total Current Liabilities
33 34 23 45 45 49 44 41 42
Short-Term Debt
17 18 6.24 23 28 25 25 21 20
Accounts Payable
5.36 4.89 7.01 10 7.93 11 6.91 7.40 7.60
Accrued Expenses
4.75 4.41 2.79 4.37 3.68 4.17 4.52 4.86 7.56
Current Deferred Revenue
1.86 1.44 1.15 0.79 0.38 1.67 1.46 0.85 0.39
Current Deferred & Payable Income Tax Liabilities
0.00 0.06 0.51 0.00 0.00 0.00 0.00 0.00 1.04
Current Employee Benefit Liabilities
2.67 3.26 2.93 3.58 3.30 4.88 4.32 4.04 4.67
Other Current Liabilities
2.21 2.04 2.27 2.37 2.31 1.81 1.77 2.19 1.43
Total Noncurrent Liabilities
15 14 12 33 29 25 23 23 20
Long-Term Debt
11 10 9.34 23 21 20 19 19 16
Noncurrent Deferred Revenue
0.00 0.00 0.00 0.00 1.41 1.14 1.10 1.06 0.93
Other Noncurrent Operating Liabilities
3.81 3.43 3.05 6.95 3.74 3.98 3.82 3.28 2.81
Total Equity & Noncontrolling Interests
84 87 91 92 92 77 76 77 78
Total Preferred & Common Equity
84 87 91 92 92 77 76 77 78
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
84 87 91 92 92 77 76 77 78
Common Stock
63 63 64 64 64 65 66 66 67
Retained Earnings
58 61 65 65 65 49 48 48 48
Treasury Stock
-35 -35 -35 -35 -35 -35 -35 -35 -35
Accumulated Other Comprehensive Income / (Loss)
-1.96 -2.56 -2.42 -2.07 -2.28 -2.37 -2.33 -2.27 -2.16

Annual Metrics And Ratios for AstroNova

This table displays calculated financial ratios and metrics derived from AstroNova's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
DEI Shares Outstanding
7,340,736.00 7,472,875.00 6,761,099.00 6,952,794.00 7,069,568.00 7,170,486.00 7,256,418.00 7,349,507.00 7,432,799.00 7,528,838.00 7,638,423.00
DEI Adjusted Shares Outstanding
7,340,736.00 7,472,875.00 6,761,099.00 6,952,794.00 7,069,568.00 7,170,486.00 7,256,418.00 7,349,507.00 7,432,799.00 7,528,838.00 7,638,423.00
DEI Earnings Per Adjusted Shares Outstanding
0.62 0.57 0.49 0.82 0.25 0.18 0.89 0.36 0.63 -1.92 -0.31
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.14% 4.00% 15.19% 20.51% -2.35% -13.05% 1.25% 21.32% 3.90% 2.16% -0.51%
EBITDA Growth
-0.13% 0.63% 5.15% 51.21% -41.12% 9.62% -20.77% 23.97% 44.63% -131.46% 249.56%
EBIT Growth
-0.20% -4.53% -17.40% 49.12% -74.47% 52.73% 3.54% 56.80% 72.37% -203.50% 110.65%
NOPAT Growth
-20.08% 3.45% -14.23% 98.26% -54.31% -54.11% 171.33% 9.19% 60.06% -188.96% 113.96%
Net Income Growth
-2.94% -6.56% -22.28% 74.38% -69.30% -27.00% 400.70% -58.61% 76.40% -408.67% 83.60%
EPS Growth
1.67% -8.20% -16.07% 72.34% -70.37% -25.00% 388.89% -59.09% 75.00% -406.35% 83.94%
Operating Cash Flow Growth
418.24% -10.02% -46.44% 34.40% -35.58% 382.13% -91.03% -310.62% 520.78% -60.76% 142.12%
Free Cash Flow Firm Growth
279.48% 32.34% -593.30% 100.47% -1,404.66% 590.71% -111.41% -2,271.75% 145.55% -263.34% 149.27%
Invested Capital Growth
-0.18% -2.64% 64.29% 8.94% 5.78% -7.45% 5.98% 30.12% -2.64% 9.13% -5.94%
Revenue Q/Q Growth
1.82% 1.96% 6.62% 3.38% -4.77% -1.88% -10.27% 0.00% 0.00% 0.00% 0.12%
EBITDA Q/Q Growth
8.36% 4.26% 22.28% 10.33% -36.08% 35.18% -10.79% 0.00% 0.00% 0.00% 193.19%
EBIT Q/Q Growth
9.81% 5.87% 14.53% 21.33% -70.07% 50.10% 26.02% 0.00% 0.00% 0.00% 108.37%
NOPAT Q/Q Growth
-2.60% -1.27% 8.71% 36.10% -49.54% -51.84% 329.12% 0.00% 0.00% 0.00% 110.81%
Net Income Q/Q Growth
6.70% -1.42% -4.03% 41.38% -67.50% -78.01% 239.61% 0.00% 0.00% 0.00% 85.89%
EPS Q/Q Growth
5.17% -1.75% -4.08% 42.11% -67.57% -77.50% 241.94% 0.00% 0.00% 0.00% 86.10%
Operating Cash Flow Q/Q Growth
-0.08% 2.00% 133.48% 17.21% -7.09% 155.49% -67.13% 0.00% 0.00% -44.76% 10.85%
Free Cash Flow Firm Q/Q Growth
228.56% 46.38% -0.60% 107.41% 39.13% -15.18% 96.74% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
6.34% 2.42% 2.06% 1.92% -2.87% -3.25% -23.70% 0.00% 0.00% 0.00% -2.78%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
40.31% 40.11% 38.80% 39.51% 36.54% 35.65% 37.23% 33.79% 33.43% 33.49% 31.65%
EBITDA Margin
9.40% 9.10% 8.31% 10.42% 6.28% 7.92% 6.20% 6.33% 8.82% -2.72% 4.08%
Operating Margin
6.27% 6.38% 4.77% 6.38% 1.82% 2.10% 3.62% 3.82% 5.94% -5.71% 0.80%
EBIT Margin
7.22% 6.63% 4.75% 5.88% 1.54% 2.70% 2.76% 3.57% 5.92% -6.00% 0.64%
Profit (Net Income) Margin
4.78% 4.29% 2.90% 4.19% 1.32% 1.11% 5.47% 1.87% 3.17% -9.58% -1.58%
Tax Burden Percent
65.49% 64.01% 63.72% 78.41% 128.39% 58.93% 91.40% 78.04% 77.29% 117.92% 93.69%
Interest Burden Percent
101.05% 101.20% 95.66% 90.91% 66.76% 69.53% 216.76% 67.02% 69.25% 135.36% -262.25%
Effective Tax Rate
34.51% 35.99% 36.28% 21.59% -28.39% 41.07% 8.60% 21.96% 22.71% 0.00% 0.00%
Return on Invested Capital (ROIC)
8.27% 8.68% 5.71% 8.71% 3.71% 1.72% 4.72% 4.35% 6.24% -5.38% 0.74%
ROIC Less NNEP Spread (ROIC-NNEP)
4.81% 7.76% 8.14% -0.71% -6.32% 0.27% 59.34% -6.24% -3.47% -34.05% -7.83%
Return on Net Nonoperating Assets (RNNOA)
-1.35% -2.55% -0.81% -0.12% -1.22% 0.04% 3.54% -1.13% -0.86% -12.08% -3.86%
Return on Equity (ROE)
6.91% 6.13% 4.90% 8.59% 2.49% 1.76% 8.26% 3.22% 5.38% -17.45% -3.11%
Cash Return on Invested Capital (CROIC)
8.45% 11.35% -42.94% 0.16% -1.91% 9.46% -1.09% -21.83% 8.91% -14.11% 6.86%
Operating Return on Assets (OROA)
8.60% 8.08% 5.23% 6.66% 1.74% 2.70% 2.82% 4.00% 6.44% -6.51% 0.68%
Return on Assets (ROA)
5.69% 5.23% 3.19% 4.75% 1.49% 1.11% 5.58% 2.09% 3.45% -10.39% -1.68%
Return on Common Equity (ROCE)
6.91% 6.13% 4.90% 8.59% 2.49% 1.76% 8.26% 3.22% 5.38% -17.45% -3.11%
Return on Equity Simple (ROE_SIMPLE)
6.72% 5.99% 5.16% 8.21% 2.46% 1.72% 7.94% 3.15% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
3.89 4.02 3.45 6.84 3.12 1.43 3.89 4.25 6.80 -6.05 0.84
NOPAT Margin
4.11% 4.08% 3.04% 5.00% 2.34% 1.24% 3.31% 2.98% 4.59% -4.00% 0.56%
Net Nonoperating Expense Percent (NNEP)
3.46% 0.92% -2.43% 9.42% 10.03% 1.45% -54.63% 10.59% 9.71% 28.67% 8.57%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 3.71% 6.07% -4.94% 0.74%
Cost of Revenue to Revenue
59.69% 59.89% 61.20% 60.49% 63.46% 64.36% 62.77% 66.21% 66.57% 66.51% 68.35%
SG&A Expenses to Revenue
7.43% 8.06% 7.85% 8.14% 8.51% 8.12% 8.13% 8.02% 7.40% 10.31% 10.88%
R&D to Revenue
7.34% 6.41% 6.57% 5.72% 6.06% 5.35% 5.75% 4.79% 4.28% 4.00% 4.51%
Operating Expenses to Revenue
34.04% 33.73% 34.03% 33.13% 34.71% 33.55% 33.61% 29.97% 27.49% 39.20% 30.85%
Earnings before Interest and Taxes (EBIT)
6.84 6.53 5.39 8.04 2.05 3.13 3.25 5.09 8.77 -9.08 0.97
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
8.90 8.96 9.42 14 8.39 9.19 7.28 9.03 13 -4.11 6.14
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.58 1.38 1.38 1.94 1.22 1.03 1.23 1.15 1.45 1.15 0.90
Price to Tangible Book Value (P/TBV)
1.87 1.61 5.16 4.88 2.57 1.91 2.01 2.01 2.31 2.43 1.83
Price to Revenue (P/Rev)
1.12 0.99 0.77 0.99 0.65 0.66 0.85 0.68 0.88 0.58 0.46
Price to Earnings (P/E)
23.51 23.08 26.69 23.65 49.54 60.03 15.51 36.60 27.92 0.00 0.00
Dividend Yield
1.93% 2.14% 2.16% 1.44% 2.27% 2.60% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.25% 4.33% 3.75% 4.23% 2.02% 1.67% 6.45% 2.73% 3.58% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.83 1.59 1.32 1.80 1.18 1.03 1.22 1.12 1.38 1.10 0.93
Enterprise Value to Revenue (EV/Rev)
0.91 0.74 0.87 1.08 0.77 0.71 0.88 0.87 1.00 0.85 0.68
Enterprise Value to EBITDA (EV/EBITDA)
9.66 8.12 10.53 10.36 12.20 8.98 14.22 13.68 11.36 0.00 16.76
Enterprise Value to EBIT (EV/EBIT)
12.57 11.15 18.39 18.35 49.86 26.32 31.92 24.27 16.91 0.00 106.48
Enterprise Value to NOPAT (EV/NOPAT)
22.12 18.10 28.75 21.58 32.75 57.55 26.63 29.07 21.81 0.00 121.96
Enterprise Value to Operating Cash Flow (EV/OCF)
11.12 10.46 26.63 29.48 31.74 5.31 74.31 0.00 12.00 26.60 8.77
Enterprise Value to Free Cash Flow (EV/FCFF)
21.63 13.84 0.00 1,198.56 0.00 10.47 0.00 0.00 15.27 0.00 13.17
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.36 0.28 0.27 0.23 0.11 0.36 0.24 0.62 0.49
Long-Term Debt to Equity
0.00 0.00 0.28 0.18 0.11 0.15 0.10 0.14 0.11 0.25 0.24
Financial Leverage
-0.28 -0.33 -0.10 0.18 0.19 0.14 0.06 0.18 0.25 0.35 0.49
Leverage Ratio
1.21 1.17 1.54 1.81 1.67 1.59 1.48 1.54 1.56 1.68 1.86
Compound Leverage Factor
1.23 1.19 1.47 1.64 1.11 1.11 3.21 1.03 1.08 2.27 -4.87
Debt to Total Capital
0.00% 0.00% 26.67% 21.91% 21.39% 18.41% 10.15% 26.26% 19.44% 38.12% 32.85%
Short-Term Debt to Total Capital
0.00% 0.00% 6.33% 7.51% 12.89% 5.82% 1.11% 15.73% 10.48% 22.56% 16.87%
Long-Term Debt to Total Capital
0.00% 0.00% 20.33% 14.40% 8.50% 12.60% 9.04% 10.52% 8.97% 15.56% 15.98%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 73.33% 78.09% 78.61% 81.59% 89.85% 73.74% 80.56% 61.88% 67.15%
Debt to EBITDA
0.00 0.00 2.46 1.37 2.32 1.83 1.26 3.33 1.67 -11.36 6.12
Net Debt to EBITDA
0.00 0.00 1.22 0.85 1.81 0.59 0.53 2.89 1.32 -10.13 5.46
Long-Term Debt to EBITDA
0.00 0.00 1.87 0.90 0.92 1.25 1.12 1.33 0.77 -4.64 2.98
Debt to NOPAT
0.00 0.00 6.71 2.86 6.22 11.76 2.35 7.07 3.21 -7.72 44.54
Net Debt to NOPAT
0.00 0.00 3.32 1.76 4.86 3.78 1.00 6.14 2.54 -6.88 39.72
Long-Term Debt to NOPAT
0.00 0.00 5.12 1.88 2.47 8.04 2.10 2.83 1.48 -3.15 21.67
Altman Z-Score
8.98 7.35 2.86 3.99 3.29 3.25 4.02 3.17 4.25 2.32 2.56
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
5.71 5.13 2.43 2.54 2.25 2.90 3.18 2.13 2.58 1.68 1.84
Quick Ratio
3.74 3.38 1.32 1.26 0.90 1.38 1.12 0.68 0.93 0.57 0.60
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
3.97 5.26 -26 0.12 -1.61 7.88 -0.90 -21 9.71 -16 7.82
Operating Cash Flow to CapEx
798.24% 1,368.70% 21.92% 164.37% 110.94% 600.85% 77.62% -1,282.10% 1,411.89% 416.14% 5,359.82%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 -64.53 0.17 -2.36 8.25 0.00 -12.71 3.60 -4.94 2.23
Operating Cash Flow to Interest Expense
0.00 0.00 9.26 6.85 4.73 16.28 0.00 -1.75 4.58 1.51 3.35
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 -33.01 2.68 0.47 13.57 0.00 -1.89 4.26 1.15 3.29
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.19 1.22 1.10 1.13 1.13 1.00 1.02 1.12 1.09 1.09 1.06
Accounts Receivable Turnover
6.43 6.35 5.95 5.96 6.17 6.24 6.80 7.36 6.63 6.83 7.49
Inventory Turnover
3.49 3.43 2.95 2.86 2.64 2.33 2.28 2.20 2.02 2.13 2.26
Fixed Asset Turnover
10.41 10.32 11.92 13.58 12.33 9.97 10.02 11.08 10.40 10.09 10.06
Accounts Payable Turnover
17.80 14.47 8.28 9.31 16.34 14.72 10.30 11.06 11.92 12.58 13.97
Days Sales Outstanding (DSO)
56.74 57.52 61.32 61.28 59.18 58.51 53.65 49.58 55.03 53.41 48.75
Days Inventory Outstanding (DIO)
104.56 106.47 123.90 127.55 138.10 156.38 160.05 166.18 180.86 170.97 161.68
Days Payable Outstanding (DPO)
20.50 25.22 44.09 39.22 22.34 24.79 35.45 33.01 30.63 29.01 26.14
Cash Conversion Cycle (CCC)
140.81 138.76 141.13 149.61 174.94 190.10 178.25 182.76 205.26 195.36 184.29
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
47 46 75 82 87 80 85 110 108 117 110
Invested Capital Turnover
2.01 2.12 1.88 1.74 1.59 1.39 1.42 1.46 1.36 1.35 1.32
Increase / (Decrease) in Invested Capital
-0.09 -1.24 29 6.71 4.73 -6.45 4.79 26 -2.91 9.82 -6.97
Enterprise Value (EV)
86 73 99 148 102 83 104 123 148 129 103
Market Capitalization
106 98 88 136 87 77 100 97 131 87 69
Book Value per Share
$9.18 $9.44 $9.41 $10.04 $10.10 $10.42 $11.16 $11.48 $12.15 $10.06 $10.06
Tangible Book Value per Share
$7.75 $8.13 $2.52 $3.99 $4.80 $5.63 $6.84 $6.60 $7.64 $4.76 $4.97
Total Capital
67 71 87 89 91 92 90 114 112 122 114
Total Debt
0.00 0.00 23 20 19 17 9.15 30 22 47 38
Total Long-Term Debt
0.00 0.00 18 13 7.72 12 8.15 12 10 19 18
Net Debt
-20 -25 11 12 15 5.42 3.88 26 17 42 34
Capital Expenditures (CapEx)
0.97 0.51 17 3.05 2.91 2.59 1.80 0.23 0.88 1.17 0.22
Debt-free, Cash-free Net Working Capital (DFCFNWC)
25 25 31 37 41 34 39 56 54 54 48
Debt-free Net Working Capital (DFNWC)
45 49 43 45 45 45 45 60 59 59 52
Net Working Capital (NWC)
45 49 37 38 33 40 44 42 47 32 32
Net Nonoperating Expense (NNE)
-0.64 -0.21 0.16 1.11 1.36 0.15 -2.54 1.59 2.10 8.44 3.22
Net Nonoperating Obligations (NNO)
-20 -25 11 12 15 5.42 3.88 26 17 42 34
Total Depreciation and Amortization (D&A)
2.07 2.43 4.03 6.20 6.33 6.06 4.04 3.94 4.29 4.97 5.18
Debt-free, Cash-free Net Working Capital to Revenue
25.93% 25.01% 27.20% 27.16% 30.61% 28.99% 33.59% 39.51% 36.55% 35.85% 31.60%
Debt-free Net Working Capital to Revenue
47.50% 50.22% 37.51% 32.67% 33.79% 38.85% 38.09% 42.28% 39.61% 39.19% 34.31%
Net Working Capital to Revenue
47.50% 50.22% 32.66% 27.77% 25.02% 34.26% 37.23% 29.65% 31.68% 20.93% 21.48%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.62 $0.57 $0.48 $0.83 $0.25 $0.18 $0.89 $0.36 $0.63 ($1.93) ($0.31)
Adjusted Weighted Average Basic Shares Outstanding
7.29M 7.42M 6.91M 6.88M 7.02M 7.10M 7.21M 7.31M 7.42M 7.51M 7.61M
Adjusted Diluted Earnings per Share
$0.61 $0.56 $0.47 $0.81 $0.24 $0.18 $0.88 $0.36 $0.63 ($1.93) ($0.31)
Adjusted Weighted Average Diluted Shares Outstanding
7.47M 7.57M 7.02M 7.08M 7.24M 7.17M 7.34M 7.37M 7.50M 7.51M 7.61M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
7.39M 7.53M 6.80M 6.99M 7.10M 7.21M 7.32M 7.40M 7.74M 7.57M 7.69M
Normalized Net Operating Profit after Tax (NOPAT)
3.89 4.02 3.45 6.84 1.70 1.43 3.89 4.25 6.80 3.33 1.05
Normalized NOPAT Margin
4.11% 4.08% 3.04% 5.00% 1.28% 1.24% 3.31% 2.98% 4.59% 2.20% 0.70%
Pre Tax Income Margin
7.30% 6.71% 4.55% 5.35% 1.03% 1.88% 5.99% 2.39% 4.10% -8.12% -1.68%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 13.41 11.00 3.01 3.28 0.00 3.03 3.25 -2.83 0.28
NOPAT to Interest Expense
0.00 0.00 8.58 9.35 4.58 1.50 0.00 2.53 2.52 -1.88 0.24
EBIT Less CapEx to Interest Expense
0.00 0.00 -28.86 6.83 -1.25 0.57 0.00 2.90 2.93 -3.19 0.21
NOPAT Less CapEx to Interest Expense
0.00 0.00 -33.69 5.19 0.32 -1.21 0.00 2.39 2.20 -2.25 0.18
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
45.26% 49.24% 59.16% 33.73% 112.11% 38.71% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
45.26% 49.24% 401.16% 33.73% 112.11% 38.71% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for AstroNova

This table displays calculated financial ratios and metrics derived from AstroNova's official financial filings.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 7/29/2023 10/28/2023 4/27/2024 8/3/2024 11/2/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026
DEI Shares Outstanding
7,417,715.00 7,424,660.00 7,743,140.00 7,513,564.00 7,520,572.00 7,528,838.00 7,574,834.00 7,596,235.00 7,636,321.00 7,638,423.00 7,692,840.00
DEI Adjusted Shares Outstanding
7,417,715.00 7,424,660.00 7,743,140.00 7,513,564.00 7,520,572.00 7,528,838.00 7,574,834.00 7,596,235.00 7,636,321.00 7,638,423.00 7,692,840.00
DEI Earnings Per Adjusted Shares Outstanding
-0.22 0.37 0.15 -0.04 0.03 -2.07 -0.05 -0.16 0.05 -0.15 0.08
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% -4.71% 0.00% 14.12% 7.65% 0.00% 14.40% -10.95% -3.10% 0.47% 4.39%
EBITDA Growth
0.00% 390.02% 0.00% 265.12% -50.81% 0.00% -9.13% -80.69% -19.49% 114.88% 42.82%
EBIT Growth
0.00% 296.61% 0.00% 166.62% -71.88% 0.00% -51.51% -191.44% -11.58% 100.85% 155.70%
NOPAT Growth
0.00% 245.16% 0.00% 188.56% -67.76% 0.00% -81.22% -166.73% 75.76% 100.45% 200.57%
Net Income Growth
0.00% 852.25% 0.00% 80.77% -91.28% 0.00% -131.84% -299.68% 57.50% 92.72% 273.67%
EPS Growth
0.00% 825.00% 0.00% 81.82% -91.89% 0.00% -133.33% -300.00% 66.67% 92.75% 260.00%
Operating Cash Flow Growth
0.00% 0.00% 0.00% 0.00% -500.51% -60.88% -36.34% 53.70% 172.14% 45.52% -31.26%
Free Cash Flow Firm Growth
0.00% -194.66% 0.00% 0.00% 75.64% 0.00% 0.00% 167.69% 196.92% 0.00% 165.87%
Invested Capital Growth
0.00% 0.00% 0.00% 23.68% 24.60% 0.00% 12.78% -12.95% -16.93% -5.94% -6.20%
Revenue Q/Q Growth
0.00% 5.70% 0.00% 22.99% -0.29% -7.57% 0.93% -4.26% 8.50% -4.17% 4.87%
EBITDA Q/Q Growth
0.00% 501.43% 0.00% 2.56% 19.58% -521.24% 117.59% -78.21% 398.59% -22.13% 68.79%
EBIT Q/Q Growth
0.00% 424.91% 0.00% -27.75% 37.16% -1,119.05% 104.80% -236.24% 232.64% -90.16% 1,337.74%
NOPAT Q/Q Growth
0.00% 509.48% 0.00% -65.10% 49.07% -878.37% 104.64% -223.99% 492.64% -97.99% 2,964.79%
Net Income Q/Q Growth
0.00% 270.19% 0.00% -126.33% 177.17% -6,599.58% 97.59% -230.59% 130.41% -400.26% 157.53%
EPS Q/Q Growth
0.00% 268.18% 0.00% -126.67% 175.00% -7,000.00% 97.58% -220.00% 131.25% -400.00% 153.33%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 7.01% -97.65% -3,027.16% 153.23% 74.13% -94.33% 1,273.90% 7.37% -17.75%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -5.06% 100.00% 0.00% 230.96% 50.43% -72.05% 19.63%
Invested Capital Q/Q Growth
0.00% 2.35% 0.00% 28.94% 3.12% -14.14% -1.22% -0.47% -1.59% -2.78% -1.49%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
27.33% 39.36% 36.32% 35.34% 33.93% 28.50% 31.69% 32.22% 36.25% 24.38% 36.65%
EBITDA Margin
-3.75% 14.25% 6.51% 5.43% 6.51% -29.68% 5.17% 1.18% 5.41% 4.40% 7.08%
Operating Margin
-3.37% 12.30% 4.08% 2.62% 3.13% -32.95% 1.51% -1.96% 3.29% 0.15% 3.97%
EBIT Margin
-3.75% 11.53% 3.73% 2.19% 3.01% -33.22% 1.58% -2.25% 2.75% 0.28% 3.87%
Profit (Net Income) Margin
-4.55% 7.33% 3.58% -0.77% 0.59% -41.75% -1.00% -3.44% 0.97% -3.02% 1.66%
Tax Burden Percent
80.57% 74.36% 158.10% 622.00% 87.59% 117.66% 124.92% 73.25% 151.20% 144.04% 76.91%
Interest Burden Percent
150.56% 85.45% 60.78% -5.63% 22.50% 106.82% -50.50% 208.99% 23.21% -743.40% 55.71%
Effective Tax Rate
0.00% 25.64% -58.10% 0.00% 12.41% 0.00% 0.00% 0.00% -51.20% 0.00% 23.09%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% -29.73% 1.51% -1.68% 5.97% 0.14% 4.13%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% -46.51% -1.53% -3.54% 2.11% -2.99% 2.58%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% -25.55% -0.47% -1.70% 1.01% -1.47% 1.18%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00% 0.00% -55.28% 1.05% -3.38% 6.98% -1.33% 5.32%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% -13.52% 0.00% 0.00% 0.00% 6.86% 7.77%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% -36.05% 1.78% -2.18% 2.69% 0.30% 4.06%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% -45.30% -1.12% -3.34% 0.94% -3.21% 1.74%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00% 0.00% -55.28% 1.05% -3.38% 6.98% -1.33% 5.32%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.84 3.43 2.13 0.74 1.11 -8.62 0.40 -0.50 1.95 0.04 1.20
NOPAT Margin
-2.36% 9.15% 6.46% 1.83% 2.74% -23.07% 1.06% -1.37% 4.97% 0.10% 3.05%
Net Nonoperating Expense Percent (NNEP)
3.42% 5.98% 8.17% 3.31% 2.58% 16.78% 3.04% 1.86% 3.86% 3.13% 1.55%
Return On Investment Capital (ROIC_SIMPLE)
- 3.00% 1.99% 0.54% 0.78% -7.04% 0.33% -0.42% 1.66% 0.03% 1.06%
Cost of Revenue to Revenue
72.67% 60.64% 63.68% 64.66% 66.07% 71.51% 68.31% 67.78% 63.75% 75.62% 63.35%
SG&A Expenses to Revenue
7.47% 7.28% 10.22% 12.63% 9.54% 8.71% 11.26% 13.94% 13.08% 3.30% 13.62%
R&D to Revenue
4.38% 4.48% 4.86% 3.48% 4.56% 3.18% 4.05% 4.37% 4.85% 4.72% 4.60%
Operating Expenses to Revenue
30.71% 27.06% 32.24% 32.72% 30.80% 61.45% 30.18% 34.18% 32.96% 24.23% 32.68%
Earnings before Interest and Taxes (EBIT)
-1.33 4.33 1.23 0.89 1.22 -12 0.60 -0.81 1.08 0.11 1.52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-1.33 5.35 2.15 2.20 2.63 -11 1.95 0.43 2.12 1.65 2.79
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.29 1.13 1.49 1.20 1.00 1.15 0.82 1.13 0.89 0.90 1.35
Price to Tangible Book Value (P/TBV)
2.20 1.86 2.33 2.82 2.18 2.43 1.66 2.27 1.82 1.83 2.64
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.58 0.40 0.57 0.46 0.46 0.69
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.23 1.11 1.43 1.14 1.00 1.10 0.88 1.09 0.93 0.93 1.25
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.85 0.66 0.83 0.70 0.68 0.89
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16.76 19.47
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 106.48 71.69
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 121.96 88.34
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 10.27 15.60 26.60 43.75 51.71 9.95 8.77 13.11
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.17 15.57
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.32 0.32 0.17 0.50 0.53 0.62 0.58 0.57 0.52 0.49 0.46
Long-Term Debt to Equity
0.13 0.12 0.10 0.25 0.23 0.25 0.26 0.25 0.25 0.24 0.21
Financial Leverage
0.27 0.26 0.13 0.36 0.38 0.55 0.30 0.48 0.48 0.49 0.46
Leverage Ratio
1.57 1.54 1.39 1.71 1.68 1.68 1.65 1.86 1.82 1.86 1.88
Compound Leverage Factor
2.36 1.32 0.84 -0.10 0.38 1.79 -0.83 3.89 0.42 -13.79 1.05
Debt to Total Capital
24.45% 24.13% 14.60% 33.22% 34.69% 38.12% 36.89% 36.44% 34.38% 32.85% 31.65%
Short-Term Debt to Total Capital
14.86% 15.37% 5.85% 16.71% 19.75% 22.56% 20.40% 20.87% 18.18% 16.87% 17.34%
Long-Term Debt to Total Capital
9.59% 8.77% 8.75% 16.50% 14.93% 15.56% 16.49% 15.57% 16.20% 15.98% 14.31%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
75.55% 75.87% 85.40% 66.78% 65.31% 61.88% 63.11% 63.56% 65.62% 67.15% 68.35%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -11.36 -10.40 -7.15 -6.11 6.12 5.14
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -10.13 -9.15 -6.51 -5.56 5.46 4.47
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 -4.64 -4.65 -3.05 -2.88 2.98 2.33
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -7.72 -6.79 -5.55 -5.16 44.54 23.35
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -6.88 -5.98 -5.06 -4.69 39.72 20.31
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 -3.15 -3.04 -2.37 -2.43 21.67 10.56
Altman Z-Score
0.00 0.00 0.00 0.00 0.00 2.24 2.28 2.53 2.50 2.54 2.89
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.23 2.28 3.07 1.87 1.83 1.68 1.67 1.71 1.82 1.84 1.76
Quick Ratio
0.67 0.80 0.95 0.64 0.65 0.57 0.55 0.51 0.59 0.60 0.62
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -106 0.00 -25 -26 0.00 -13 17 25 7.01 8.39
Operating Cash Flow to CapEx
0.00% 150.83% 1,403.25% 47.93% -1,852.34% 3,194.94% 7,325.00% 529.79% 3,977.91% 2,915.08% 8,391.67%
Free Cash Flow to Firm to Interest Expense
0.00 -168.68 0.00 -26.27 -27.42 0.00 -14.20 18.84 30.33 7.84 12.43
Operating Cash Flow to Interest Expense
0.00 1.88 14.32 0.17 -5.02 2.98 4.90 0.28 4.14 4.11 4.48
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.63 13.30 -0.19 -5.29 2.89 4.83 0.23 4.03 3.97 4.42
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.00 1.09 1.13 0.97 0.98 1.06 1.05
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 6.83 7.96 7.22 6.60 7.49 7.08
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 2.13 2.18 2.04 2.12 2.26 2.14
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 10.09 9.84 8.48 9.09 10.06 9.77
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 12.58 11.46 11.62 12.93 13.97 10.75
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 53.41 45.88 50.55 55.30 48.75 51.56
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 170.97 167.33 179.07 172.49 161.68 170.56
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 29.01 31.85 31.42 28.23 26.14 33.95
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 195.36 181.36 198.20 199.55 184.29 188.17
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
107 110 103 133 137 117 116 115 114 110 109
Invested Capital Turnover
0.00 0.00 0.00 0.00 0.00 1.29 1.43 1.22 1.20 1.32 1.35
Increase / (Decrease) in Invested Capital
0.00 110 0.00 25 27 0.00 13 -17 -23 -6.97 -7.19
Enterprise Value (EV)
132 121 147 151 137 129 102 125 105 103 136
Market Capitalization
109 99 136 110 92 87 63 86 69 69 105
Book Value per Share
$11.38 $11.70 $11.78 $12.21 $12.26 $10.06 $10.11 $9.98 $10.07 $10.06 $10.08
Tangible Book Value per Share
$6.69 $7.14 $7.53 $5.20 $5.63 $4.76 $5.00 $4.97 $4.94 $4.97 $5.15
Total Capital
112 115 107 137 141 122 121 119 117 114 113
Total Debt
27 28 16 46 49 47 45 43 40 38 36
Total Long-Term Debt
11 10 9.34 23 21 19 20 19 19 18 16
Net Debt
23 23 12 41 45 42 39 40 37 34 31
Capital Expenditures (CapEx)
0.00 0.79 0.49 0.34 0.26 0.08 0.06 0.05 0.09 0.13 0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)
53 56 50 57 61 54 52 52 51 48 47
Debt-free Net Working Capital (DFNWC)
58 61 54 62 66 59 57 56 55 52 52
Net Working Capital (NWC)
41 43 47 39 38 32 33 31 34 32 32
Net Nonoperating Expense (NNE)
0.78 0.68 0.95 1.05 0.87 6.98 0.78 0.75 1.57 1.17 0.55
Net Nonoperating Obligations (NNO)
23 23 12 41 45 42 39 40 37 34 31
Total Depreciation and Amortization (D&A)
0.00 1.02 0.92 1.31 1.41 1.33 1.35 1.24 1.04 1.54 1.26
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 35.85% 33.28% 34.56% 34.06% 31.60% 31.07%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 39.19% 36.71% 37.10% 36.46% 34.31% 34.15%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 20.93% 20.85% 20.68% 22.29% 21.48% 21.22%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.22) $0.37 $0.16 ($0.04) $0.03 ($2.08) ($0.05) ($0.16) $0.05 ($0.15) $0.09
Adjusted Weighted Average Basic Shares Outstanding
7.42M 7.43M 7.46M 7.52M 7.52M 7.51M 7.56M 7.61M 7.63M 7.61M 7.68M
Adjusted Diluted Earnings per Share
($0.22) $0.37 $0.15 ($0.04) $0.03 ($2.07) ($0.05) ($0.16) $0.05 ($0.15) $0.08
Adjusted Weighted Average Diluted Shares Outstanding
7.42M 7.48M 7.63M 7.52M 7.58M 7.51M 7.56M 7.61M 7.70M 7.61M 7.77M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
7.42M 7.43M 7.51M 7.52M 7.53M 7.57M 7.60M 7.64M 7.64M 7.69M 7.75M
Normalized Net Operating Profit after Tax (NOPAT)
-0.84 3.43 0.94 0.74 1.11 -8.62 0.40 -0.50 1.11 0.04 1.20
Normalized NOPAT Margin
-2.36% 9.15% 2.86% 1.83% 2.74% -23.07% 1.06% -1.37% 2.83% 0.10% 3.05%
Pre Tax Income Margin
-5.65% 9.86% 2.27% -0.12% 0.68% -35.49% -0.80% -4.70% 0.64% -2.10% 2.16%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-1.98 6.87 2.55 0.95 1.29 -14.67 0.66 -0.92 1.30 0.12 2.26
NOPAT to Interest Expense
-1.24 5.45 4.42 0.79 1.17 -10.19 0.45 -0.56 2.35 0.04 1.78
EBIT Less CapEx to Interest Expense
0.00 5.63 1.53 0.59 1.02 -14.76 0.60 -0.97 1.20 -0.02 2.20
NOPAT Less CapEx to Interest Expense
0.00 4.20 3.39 0.43 0.90 -10.28 0.38 -0.61 2.25 -0.10 1.73
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

AstroNova’s latest quarter showed a clear turnaround from the prior quarter, but the longer-term picture is still mixed. For Q1 fiscal 2027, revenue rose to $39.4 million from $37.5 million in Q4 2026, and the company returned to profitability with net income of $653,000 after a loss of $1.1 million in the prior quarter. Operating cash flow also improved to $3.0 million, which is a strong sign that the business is generating cash from operations again.

That said, the company is still carrying meaningful leverage and working-capital pressure. Short-term debt was $19.7 million and long-term debt was $16.2 million at the end of Q1 2027, while current liabilities of $42.4 million remained elevated. Inventories were also very large at $43.9 million, which can be a risk if demand softens or if the company needs to discount product to move stock.

  • Q1 2027 revenue increased to $39.4 million, up from $37.5 million in Q4 2026, showing modest top-line growth.
  • Net income rebounded to $653,000 in Q1 2027 after a $1.1 million loss in Q4 2026.
  • Operating cash flow improved sharply to $3.0 million, supporting liquidity and debt service.
  • Gross profit expanded to $14.4 million in Q1 2027, with gross margin improving versus the prior quarter.
  • The company ended Q1 2027 with $4.7 million in cash, modestly higher than the prior quarter.
  • Capital spending remained very light at just $36,000, suggesting limited near-term investment needs.
  • Shares outstanding remained fairly stable, so dilution was not a major issue in the latest quarter.
  • Debt remains heavy, with $35.9 million combined short- and long-term debt on the balance sheet.
  • Inventories were still elevated at $43.9 million, tying up a large amount of working capital.
  • The business has been volatile over the past year, swinging from profitability to losses and back again.

Looking at the trend over the last four years of quarters provided, AstroNova has had uneven operating performance. Revenue has generally been in the high-$30 million range per quarter, but earnings have swung materially because of changes in operating expense, interest expense, and occasional impairment charges. In several quarters, operating income was weak or negative despite decent gross profit, which suggests the company’s cost structure remains a key issue.

Balance sheet trends are somewhat constructive, but not without risk. Total equity was $77.5 million in Q1 2027, down slightly from Q1 2026 but still solid. However, liabilities were also substantial at $62.3 million, and debt reduction has not been consistent. Cash generation is encouraging, but the company will likely need continued operational discipline to keep leverage manageable and avoid pressure from its working capital needs.

Bottom line: AstroNova’s latest quarter was a positive step, especially on earnings and cash flow, but investors should view the name as a turnaround story that still carries balance sheet and execution risk.

07/20/26 07:47 AM ETAI Generated. May Contain Errors.

AstroNova Financials - Frequently Asked Questions

According to the most recent income statement we have on file, AstroNova's fiscal year ends in January. Their fiscal year 2026 ended on January 31, 2026.

AstroNova's net income appears to be on a downward trend, with a most recent value of -$2.38 million in 2026, falling from $4.53 million in 2016. The previous period was -$14.49 million in 2025. See where experts think AstroNova is headed by visiting AstroNova's forecast page.

AstroNova's total operating income in 2026 was $1.21 million, based on the following breakdown:
  • Total Gross Profit: $47.63 million
  • Total Operating Expenses: $46.43 million

Over the last 10 years, AstroNova's total revenue changed from $94.66 million in 2016 to $150.52 million in 2026, a change of 59.0%.

AstroNova's total liabilities were at $60.70 million at the end of 2026, a 13.1% decrease from 2025, and a 473.2% increase since 2016.

In the past 10 years, AstroNova's cash and equivalents has ranged from $3.95 million in 2023 to $18.10 million in 2017, and is currently $4.07 million as of their latest financial filing in 2026.

Over the last 10 years, AstroNova's book value per share changed from 9.18 in 2016 to 10.06 in 2026, a change of 9.6%.



Financial statements for NASDAQ:ALOT last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners